This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Genzyme: Analysts' Upgrades, Downgrades

Genzyme (GENZ) price target boosted at BofA/Merrill to $54 from $47 based on switching from a multiple-based valuation to discounted cashflow, as investors view GENZ as a break up saleable company. Maintain Underperform rating.

Genzyme (GENZ) estimates, target reduced at Goldman. Shares of GENZ now seen reaching $51. Estimates also cut, as the company is facing higher expenses. Sell rating.

Hewlett-Packard (HPQ - Get Report) price target increased at BofA/Merrill to $62 from $60 after solid 1Q10 results. Estimates raised through 2012.

Hewlett-Packard (HPQ - Get Report) numbers raised at Goldman. HPQ estimates were increased through 2011. Company is gaining share and has strong operating leverage. Buy rating and new $61 price target.

Life Technologies (LIFE) estimates cut at Morgan Stanley. LIFE estimates were lowered through 2012. Recent debt offering increases interest expense, but still makes strategic sense. Overweight rating and $57 price target.

Las Vegas Sands (LVS) estimates lowered at UBS. LVS estimates were cut through 2010. Weak Las Vegas results will continue to weigh on results. Buy rating and $20 price target.

Nabors (NBR) estimates, target increased at UBS. Shares of NBR now seen reaching $25, according to UBS. Estimates also boosted, because of better U.S. pricing. Neutral rating.

Newfield Exploration (NFX) numbers increased at Goldman. NFX estimates were raised through 2012. Company can deliver double-digit production and free cash flow growth. Buy rating and new $63 price target.

NetApp (NTAP) target, estimates boosted at Credit Suisse. NTAP price target raised to $29 from $27 on signs of networked storage recovery. 2010 and 2011 EPS estimates surged to $1.43 and $1.62, respectively. Neutral rating.

4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AMAT $21.80 0.00%
AEO $17.15 0.00%
BHI $68.09 0.00%
DE $88.39 0.00%
HPQ $33.26 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs